Potential mechanisms underlying the Runx2 induced osteogenesis of bone marrow mesenchymal stem cells

American Journal of Translational Research

Volumn 7, Issue 12, 2015, Pages 2527-2535

  Xu, Jia Hai ^a   Li, Zhang Hua ^a   Hou, Yu Dong ^a   Fang, Wei Jun ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Bone marrow derived mesenchymal stem cells; Osteogenic differentiation; Runx2

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; BONE SIALOPROTEIN; COLLAGEN TYPE 1; FIBROBLAST GROWTH FACTOR 2; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; INTERLEUKIN 1BETA; LYMPHOID ENHANCER FACTOR 1; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; OSTEOCALCIN; OSTEOPONTIN; SMAD PROTEIN; SONIC HEDGEHOG PROTEIN; STRESS ACTIVATED PROTEIN KINASE; T CELL FACTOR PROTEIN; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; WNT PROTEIN;

BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARTILAGE CELL; CELL CYCLE PROGRESSION; CELL DIFFERENTIATION; CELL PROLIFERATION; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84956875497     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Lin GL and Hankenson KD. Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiation. J Cell Biochem 2011; 112: 3491-3501.
2. Caplan AI. Why are MSCs therapeutic? New data: new insight. J Pathol 2009; 217: 318-324.
3. Drissi H, Luc Q, Shakoori R, Chuva De Sousa Lopes S, Choi JY, Terry A, Hu M, Jones S, Neil JC, Lian JB, Stein JL, Van Wijnen AJ and Stein GS. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol 2000; 184: 341-350.
4. Ducy P, Zhang R, Geoffroy V, Ridall AL and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754.
5. Javed A, Guo B, Hiebert S, Choi JY, Green J, Zhao SC, Osborne MA, Stifani S, Stein JL, Lian JB, van Wijnen AJ and Stein GS. Groucho/TLE/ R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/ PEBP2(alpha)) dependent activation of tissuespecific gene transcription. J Cell Sci 2000; 113: 2221-2231.
6. Zheng H, Guo Z, Ma Q, Jia H and Dang G. Cbfa1/osf2 transduced bone marrow stromal cells facilitate bone formation in vitro and in vivo. Calcif Tissue Int 2004; 74: 194-203.
7. Lee MH, Javed A, Kim HJ, Shin HI, Gutierrez S, Choi JY, Rosen V, Stein JL, van Wijnen AJ, Stein GS, Lian JB and Ryoo HM. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem 1999; 73: 114-125.
8. Liu W, Toyosawa S, Furuichi T, Kanatani N, Yoshida C, Liu Y, Himeno M, Narai S, Yamaguchi A and Komori T. Overexpression of Cbfa1 in osteoblasts inhibits osteoblast maturation and causes osteopenia with multiple fractures. J Cell Biol 2001; 155: 157-166.
9. Galindo M, Kahler RA, Teplyuk NM, Stein JL, Lian JB, Stein GS, Westendorf JJ and van Wijnen AJ. Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts. J Mol Histol 2007; 38: 501-506.
10. Li ZH, Liao W, Zhao Q, Huan T, Feng P, Wei X, Yi Y and Shao NS. Effect of Cbfa1 on osteogenic differentiation of mesenchymal stem cells under hypoxia condition. Int J Clin Exp Med 2014; 7: 540-548.
11. Zelzer E, Glotzer DJ, Hartmann C, Thomas D, Fukai N, Soker S and Olsen BR. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 2001; 106: 97-106.
12. Wagner DO, Sieber C, Bhushan R, Borgermann JH, Graf D and Knaus P. BMPs: from bone to body morphogenetic proteins. Sci Signal 2010; 3: mr1.
13. Chen G, Deng C and Li YP. TGF-beta and BMP signaling in osteoblast differentiation and bone formation. Int J Biol Sci 2012; 8: 272-288.
14. Javed A, Bae JS, Afzal F, Gutierrez S, Pratap J, Zaidi SK, Lou Y, van Wijnen AJ, Stein JL, Stein GS and Lian JB. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal. J Biol Chem 2008; 283: 8412-8422.
15. Nishimura R, Kato Y, Chen D, Harris SE, Mundy GR and Yoneda T. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12. J Biol Chem 1998; 273: 1872-1879.
16. Lee KS, Hong SH and Bae SC. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene 2002; 21: 7156-7163.
17. Grogan SP, Olee T, Hiraoka K and Lotz MK. Repression of chondrogenesis through binding of notch signaling proteins HES-1 and HEY-1 to N-box domains in the COL2A1 enhancer site. Arthritis Rheum 2008; 58: 2754-2763.
18. Hill CR, Yuasa M, Schoenecker J and Goudy SL. Jagged1 is essential for osteoblast development during maxillary ossification. Bone 2014; 62: 10-21.
19. Hilton MJ, Tu X, Wu X, Bai S, Zhao H, Kobayashi T, Kronenberg HM, Teitelbaum SL, Ross FP, Kopan R and Long F. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat Med 2008; 14: 306-314.
20. Watanabe K and Ikeda K. [Osteoblast differentiation and bone formation]. Nihon Rinsho 2009; 67: 879-886.
21. Zamurovic N, Cappellen D, Rohner D and Susa M. Coordinated activation of notch, Wnt, and transforming growth factor-beta signaling pathways in bone morphogenic protein 2-induced osteogenesis. Notch target gene Hey1 inhibits mineralization and Runx2 transcriptional activity. J Biol Chem 2004; 279: 37704-37715.
22. Sakamoto K, Tamamura Y, Katsube K and Yamaguchi A. Zfp64 participates in Notch signaling and regulates differentiation in mesenchymal cells. J Cell Sci 2008; 121: 1613-1623.
23. Larabee JL, Shakir SM, Barua S and Ballard JD. Increased cAMP in monocytes augments Notch signaling mechanisms by elevating RBPJ and transducin-like enhancer of Split (TLE). J Biol Chem 2013; 288: 21526-21536.
24. Watanabe T, Oyama T, Asada M, Harada D, Ito Y, Inagawa M, Suzuki Y, Sugano S, Katsube K, Karsenty G, Komori T, Kitagawa M and Asahara H. MAML1 enhances the transcriptional activity of Runx2 and plays a role in bone development. PLoS Genet 2013; 9: e1003132.
25. Fakhry M, Hamade E, Badran B, Buchet R and Magne D. Molecular mechanisms of mesenchymal stem cell differentiation towards osteoblasts. World J Stem Cells 2013; 5: 136-148.
26. Boland GM, Perkins G, Hall DJ and Tuan RS. Wnt 3a promotes proliferation and suppresses osteogenic differentiation of adult human mesenchymal stem cells. J Cell Biochem 2004; 93: 1210-1230.
27. Liu G, Vijayakumar S, Grumolato L, Arroyave R, Qiao H, Akiri G and Aaronson SA. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol 2009; 185: 67-75.
28. Kook SH, Heo JS and Lee JC. Crucial roles of canonical Runx2-dependent pathway on Wnt1-induced osteoblastic differentiation of human periodontal ligament fibroblasts. Mol Cell Biochem 2015; 402: 213-223.
29. Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS and Lian JB. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem 2005; 280: 33132-33140.
30. Nemoto E, Sakisaka Y, Tsuchiya M, Tamura M, Nakamura T, Kanaya S, Shimonishi M and Shimauchi H. Wnt3a signaling induces murine dental follicle cells to differentiate into cementoblastic/ osteoblastic cells via an osterix-dependent pathway. J Periodontal Res 2015; [Epub ahead of print].
31. Mendoza-Villanueva D, Zeef L and Shore P. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFbeta-dependent expression of the Wnt antagonist, sclerostin. Breast Cancer Res 2011; 13: R106.
32. Kang H and Hata A. The role of microRNAs in cell fate determination of mesenchymal stem cells: balancing adipogenesis and osteogenesis. BMB Rep 2015; 48: 319-323.
33. Huang J, Zhao L, Xing L and Chen D. MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells 2010; 28: 357-364.
34. Hassan MQ, Gordon JA, Beloti MM, Croce CM, van Wijnen AJ, Stein JL, Stein GS and Lian JB. A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A 2010; 107: 19879-19884.
35. Hu N, Feng C, Jiang Y, Miao Q and Liu H. Regulative Effect of Mir-205 on Osteogenic Differentiation of Bone Mesenchymal Stem Cells (BMSCs): Possible Role of SATB2/Runx2 and ERK/ MAPK Pathway. Int J Mol Sci 2015; 16: 10491-10506.
36. Park J, Wada S, Ushida T and Akimoto T. The microRNA-23a has limited roles in bone formation and homeostasis in vivo. Physiol Res 2015; 64: 711-9.
37. van der Deen M, Taipaleenmaki H, Zhang Y, Teplyuk NM, Gupta A, Cinghu S, Shogren K, Maran A, Yaszemski MJ, Ling L, Cool SM, Leong DT, Dierkes C, Zustin J, Salto-Tellez M, Ito Y, Bae SC, Zielenska M, Squire JA, Lian JB, Stein JL, Zambetti GP, Jones SN, Galindo M, Hesse E, Stein GS and van Wijnen AJ. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma. J Biol Chem 2013; 288: 21307-21319.
38. Zhang Y, Xie RL, Gordon J, LeBlanc K, Stein JL, Lian JB, van Wijnen AJ and Stein GS. Control of mesenchymal lineage progression by microRNAs targeting skeletal gene regulators Trps1 and Runx2. J Biol Chem 2012; 287: 21926-21935.
39. Huang S, Wang S, Bian C, Yang Z, Zhou H, Zeng Y, Li H, Han Q and Zhao RC. Upregulation of miR-22 promotes osteogenic differentiation and inhibits adipogenic differentiation of human adipose tissue-derived mesenchymal stem cells by repressing HDAC6 protein expression. Stem Cells Dev 2012; 21: 2531-2540.
40. Yu S, Geng Q, Ma J, Sun F, Yu Y, Pan Q and Hong A. Heparin-binding EGF-like growth factor and miR-1192 exert opposite effect on Runx2-induced osteogenic differentiation. Cell Death Dis 2013; 4: e868.
41. Naganawa T, Xiao L, Coffin JD, Doetschman T, Sabbieti MG, Agas D and Hurley MM. Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice. J Cell Biochem 2008; 103: 1975-1988.
42. Huang RL, Yuan Y, Tu J, Zou GM and Li Q. Opposing TNF-alpha/IL-1beta-and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation. Cell Death Dis 2014; 5: e1187.
43. Lian JB, Stein GS, van Wijnen AJ, Stein JL, Hassan MQ, Gaur T and Zhang Y. MicroRNA control of bone formation and homeostasis. Nat Rev Endocrinol 2012; 8: 212-227.